Home CytRx Announces Partial Clinical Hold Affecting Aldoxorubicin Clinical Trials
 

Keywords :   


CytRx Announces Partial Clinical Hold Affecting Aldoxorubicin Clinical Trials

2014-11-19 04:46:13| Biotech - Topix.net

CytRx Corporation , a biopharmaceutical research and development company specializing in oncology, today announced that the Company has received notice from the United States Food and Drug Administration that its clinical trials for aldoxorubicin have been placed on partial clinical hold. All currently enrolled patients can continue receiving aldoxorubicin treatment, or comparator drugs, as per study protocols, but no new patients can be enrolled until the clinical hold is lifted.

Tags: hold clinical partial affecting

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11Idées de CADRES No.83
23.11 12BOX PREMIUMpack 25th
23.11V2box
23.11
23.11 &
23.11DVD('97/)E11387
23.117
23.11
More »